EBS
Emergent BioSolutions Inc
Price:  
6.38 
USD
Volume:  
926,633.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

EBS Relative Valuation

-530.4%
Upside

As of 2025-07-01, the Relative Valuation of Emergent BioSolutions Inc (EBS) is (27.46) USD. This relative valuation is based on P/E multiples. With the latest stock price at 6.38 USD, the upside of Emergent BioSolutions Inc based on Relative Valuation is -530.4%.

The range of the Relative Valuation is (27.15) - (26.96) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 11.2x - 12.7x 12.0x
Forward P/E multiples 10.3x - 11.1x 10.7x
Fair Price (27.15) - (26.96) (27.46)
Upside -525.6% - -522.6% -530.4%
6.38 USD
Stock Price
(27.46) USD
Fair Price

EBS Relative Valuation - Historical P/E Data

Date P/E
2025-06-30 -2.63
2025-06-27 -2.62
2025-06-26 -2.82
2025-06-25 -2.77
2025-06-24 -2.79
2025-06-23 -2.69
2025-06-20 -2.57
2025-06-18 -2.60
2025-06-17 -2.57
2025-06-16 -2.57
2025-06-13 -2.58
2025-06-12 -2.72
2025-06-11 -2.75
2025-06-10 -2.78
2025-06-09 -2.68
2025-06-06 -2.73
2025-06-05 -2.50
2025-06-04 -2.61
2025-06-03 -2.64
2025-06-02 -2.60
2025-05-30 -2.61
2025-05-29 -2.66
2025-05-28 -2.68
2025-05-27 -2.61
2025-05-23 -2.64
2025-05-22 -2.68
2025-05-21 -2.65
2025-05-20 -2.86
2025-05-19 -2.78
2025-05-16 -2.74
2025-05-15 -2.26
2025-05-14 -2.33
2025-05-13 -2.43
2025-05-12 -2.41
2025-05-09 -2.33
2025-05-08 -2.62
2025-05-07 -1.96
2025-05-06 -1.98
2025-05-05 -2.04
2025-05-02 -2.12
2025-05-01 -2.03
2025-04-30 -2.20
2025-04-29 -2.25
2025-04-28 -2.25
2025-04-25 -2.26
2025-04-24 -2.21
2025-04-23 -2.05
2025-04-22 -1.95
2025-04-21 -1.87
2025-04-17 -1.91